Moreover, Huang et al. reported that AP-2α suppressed hepatocellular carcinoma survival via the downregulation of, e.g., ERK, CCND1 or CD133 [57], the latter having a significant influence on BLCA viability [58]. The gene discussed is PROM1; the disease is hepatocellular carcinoma.